TGFB1 and cancer: IL-6 acts directly on cancer cells to induce the expression of STAT3 target genes, including Cyclin D1, BCL2-like protein 1 (BCL-xL), VEGF, MMPs, IL-10, and TGF-β, thereby contributing to the maintenance of CSC properties [93].